Novanta Inc.

NasdaqGS:NOVT Stock Report

Market Cap: US$5.5b

Novanta Future Growth

Future criteria checks 3/6

Novanta is forecast to grow earnings and revenue by 32.5% and 8.6% per annum respectively while EPS is expected to grow by 32.3% per annum.

Key information

32.5%

Earnings growth rate

32.3%

EPS growth rate

Electronic earnings growth17.8%
Revenue growth rate8.6%
Future return on equityn/a
Analyst coverage

Low

Last updated19 Dec 2024

Recent future growth updates

Recent updates

Novanta Inc.'s (NASDAQ:NOVT) Business Is Yet to Catch Up With Its Share Price

Dec 21
Novanta Inc.'s (NASDAQ:NOVT) Business Is Yet to Catch Up With Its Share Price

Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

Oct 15
Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S

Sep 12
What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S

Novanta Inc.: Overpriced In A Weak Demand Market. Here's Why It's A Hold

Sep 02

Is It Too Late To Consider Buying Novanta Inc. (NASDAQ:NOVT)?

Aug 24
Is It Too Late To Consider Buying Novanta Inc. (NASDAQ:NOVT)?

Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price

Aug 02
Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price

Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively

Jun 22
Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively

Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

May 30
Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)

May 08
Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)

Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Feb 24
Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Feb 05
Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Getting In Cheap On Novanta Inc. (NASDAQ:NOVT) Is Unlikely

Dec 29
Getting In Cheap On Novanta Inc. (NASDAQ:NOVT) Is Unlikely

Novanta Non-GAAP EPS of $0.78 beats by $0.06, revenue of $215.34M beats by $6.27M, raises FY guidance

Aug 09

Earnings and Revenue Growth Forecasts

NasdaqGS:NOVT - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,1201201541804
12/31/20251,042961221504
12/31/2024952631121374
9/27/202492360115136N/A
6/28/202490062133158N/A
3/29/202489369120143N/A
12/31/202388273100120N/A
9/29/202388876104122N/A
6/30/2023890777792N/A
3/31/2023876737390N/A
12/31/2022861747091N/A
9/30/2022841735779N/A
7/1/2022796645378N/A
4/1/2022748585883N/A
12/31/2021707507295N/A
10/1/20216554992112N/A
7/2/202162144124141N/A
4/2/202159844132146N/A
12/31/202059145127140N/A
10/2/202060341117129N/A
7/3/2020614428294N/A
4/3/2020624406276N/A
12/31/2019626415363N/A
9/27/2019623433850N/A
6/28/2019629565670N/A
3/29/2019625575975N/A
12/31/2018614517390N/A
9/28/2018605397490N/A
6/29/201859118N/A74N/A
3/30/201855912N/A71N/A
12/31/201752140N/A63N/A
9/29/201747348N/A54N/A
6/30/201742555N/A54N/A
3/31/201740354N/A52N/A
12/31/201638522N/A48N/A
9/30/201637620N/A43N/A
7/1/201637119N/A43N/A
4/1/201636934N/A36N/A
12/31/201537436N/A33N/A
10/2/20153771N/A34N/A
7/3/20153800N/A37N/A
4/3/2015380-16N/A47N/A
12/31/2014365-17N/A42N/A
9/26/201435316N/A48N/A
6/27/201433813N/A52N/A
3/28/201432111N/A46N/A
12/31/201331710N/A49N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: NOVT's forecast earnings growth (32.5% per year) is above the savings rate (2.6%).

Earnings vs Market: NOVT's earnings (32.5% per year) are forecast to grow faster than the US market (15.2% per year).

High Growth Earnings: NOVT's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: NOVT's revenue (8.6% per year) is forecast to grow slower than the US market (9.1% per year).

High Growth Revenue: NOVT's revenue (8.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if NOVT's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:07
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/27
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Novanta Inc. is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert MasonBaird
Ishan MajumdarBaptista Research
Andrew BuscagliaBerenberg